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1. Introduction 
Diabetes mellitus is a chronic debilitating disease affecting over 23 million children and 
adults in the United States. Many of the ill effects of this disease lie in part with uncontrolled 
glucose levels in the body. Hypoglycemia increases the risk of cardiovascular and 
cerebrovascular events, progression of dementia, injurious falls, emergency department 
visits, and hospitalizations (Desouza, 2003; Leese, 2003; Schwartz, 2008; Whitmer, 2009).  
Hypoglycemia-associated autonomic failure is another major complication that diabetic 
individuals go through when their glucose levels are not properly regulated. In this 
complication, antecedent hypoglycemia causes both defective glucose counter-regulation and 
hypoglycemia unawareness (by reducing autonomic and neurogenic symptom response) thus 
making it difficult for patients to properly sense a hypoglycemic event and thus cause further 
complications in the future (Cranston, 1994; Cryer, 2004; Dagogo-Jack, 1994, Fanelli, 1994). 
Hyperglycemia is associated with secondary damage to many organ systems especially the 
kidneys, eyes, nerves and blood vessels. Hyperglycemia is associated with both macro- and 
microvascular complications. The macrovascular complications include increased risk of 
myocardial infarction as well as stroke, cerebrovascular disease, and coronary artery disease 
(Kannel, 1979; Lehto et al., 1996). On the microvascular level, hyperglycemia is associated 
with vascular damage, leakage, and edema. Such inflammation can lead to occlusion and 
ischemia as well as nerve damage (Kannel, 1979).  
Since the Diabetes Complications and Control Trial (DCCT) established hemoglobin A1C as 
the gold standard of glycemic control there has been a lot of research on other factors that 
might better predict the risk of diabetic complications. One such factor has been glycemic 
variability. Large changes in glycemic levels lead to production of reactive oxygen species 
(ROS), which in turn accelerate the micro- and macrovascular complications of diabetes. It is 
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also possible that neglecting these variations in glycemic control could lead to 
misinterpretation of the risk of diabetic complications even if the mean A1C levels fall 
within the normal accepted range (Hirsch & Brownlee, 2005). 
However, for a variety of reasons ranging from biomedical to psychosocial it is difficult to 
achieve optimal glycemic control (Amir et al., 1990). Continuous glucose monitoring (CGM) 
provides a useful method to help monitor glucose values and to provide useful feedback to 
more effectively control glycemic levels (Klonoff, 2005). In a multicenter clinical trial 
studying two groups, one using CGM and the other using self-glucose monitoring it was 
found that there was a significant improvement in hemoglobin A1C in patients using CGM 
as compared to patients using self-monitored finger stick glucose measurements after a 26 
week trial (Tamborlane et al., 2008). 
To further study some of these observations, in our study we used CGM over a 72 hour 
period to examine 84 male patients who had been diagnosed with either Type I or II 
diabetes. Our goal was to characterize the time the patient spent in a hypo-, hyper-, and eu-
glycemic state with respect to age and the treatment type the patient received (oral 
medication vs. insulin). 
2. Methods 
Eighty-four treated adult male diabetic patients (18 oral treatment, 51 insulin only, and 15 
both oral and insulin) were studied. All patients had attended a comprehensive diabetes 
clinic on a regular basis and had received diabetes education including diet, exercise and 
self-monitoring of blood glucose (SMBG) instructions.  
Assessment of clinical data included age, sex distribution, and duration of diabetes, body 
mass index, diabetic complication (i.e. Diabetic neuropathy, retinopathy, nephropathy, 
cardiovascular disease and peripheral vascular disease). Pertinent laboratory data included 
HbAlC, plasma glucose, creatinine, liver function tests, lipid levels and microalbuminuria. 
The patient’s home medications were also reviewed for potential effect on glucose 
homeostasis.  
A CGMS sensor was inserted and calibrated according to the Minimed Medtronic 
procedure. Patients were instructed to continue with their regular lifestyle, to keep a food 
diary and to record event markers into the monitor e.g. insulin administration, exercise, 
SMBG and hypoglycemic episode. After 72 hours, the monitor was removed and the data 
were downloaded using Minimed Solutions Software version 2.0b. 
2.1 Statistical analyses 
Standard procedures were used to calculate the means, SD, SEM, hyperglycemia frequency 
and correlation coefficients. SMBG glucose values were paired with corresponding CGMS 
glucose values for linear regression analyses. Blood glucose concentration >140 mg/dL for 
at least 30 minutes indicated hyperglycemia. Hyperglycemic prevalence was calculated as 
the percentage of a specified time period spent during hyperglycemia. Changes in blood 
glucose > 100mg/dL within a 60-min period were defined as rapid glucose excursions.  
3. Results  
During the 3-day evaluation, 84 men provided a continuous measure of blood glucose levels 
using a CGM device4. The participants mean age was = 66.17 (± 11.36) years, with N=36 
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subjects younger than 65 and N= 48 subjects 65 and older. Of the 84 patients, 18 were on oral 
medications alone, 51 were on insulin alone, while 15 were on both. Table 1 provides 
demographic information including age, BMI, systolic blood pressure and HbA1C.  The 
correlations among BMI, systolic BP, hemoglobin A1C and age are presented in Table 2. The 
analysis of the glycemic levels were divided into 3 time periods: 6 am – 6 pm (daytime), 6 
pm – midnight (evening), and midnight – 6 am (early morning). 
 
Age x¯  = 66.17 ± 11.36 
BMI x¯ =  30.3 ±  5.86 
Systolic Blood Pressure x¯ = 135.04 ± 18.9 
HbA1C x¯ = 7.76 ± 1.62 
Table 1. Demographics (N = 84) 
 
 Age BMI HbA1c Systolic BP 
Age 1 -0.15 -0.41* 0.32* 
BMI -0.15 1 -0.11 -0.06 
HbA1c -0.41* -0.11 1 -0.15 
Systolic BP 0.32* -0.06 -0.15 1 
*p <.05; **p < .01  
Table 2. Zero order correlations    
Overall, a greater percentage of time was spent in hyperglycemia during the day (57.86% ± 
14.59) than at night (16.11% ± 10.40), t(83) = 16.50, p <0.01. The analysis of hypoglycemic and 
euglycemic states showed no statistically significant difference (multiple regression 
analysis) between time intervals when comparing the association with age, BMI, treatment, 
HbA1c, or any other predictive variables.  Also no significant findings were seen in the 
evening hours (6 pm to midnight) when examining the same variables for either age or 
treatment type for any glycemic state. 
The effects of Age Grouping (<65 and ≥65) on the percentage time that subjects were in the 
hyperglycemic state during the early morning was evaluated with multiple regression 
analyses using covariates (BMI, systolic blood pressure, and hemoglobin A1C) that were 
found to be statistically significantly related to hyperglycemic events. The model outlined in 
Table 3 included BMI entered on the first step, systolic blood pressure entered on the second 
step and HemoglobinA1c (HbA1C) entered on the third step. The same analysis was done 
for the daytime interval. Increasing values of HbA1C were associated with a significantly 
greater percentage of time in the hyperglycemic state, as expected, but only during the early 
morning hours. 
However, BMI and systolic blood pressure were not significant predictors of percentage 
time in the hyperglycemic state. On the other hand, subjects older than 65 years exhibited a 
significantly greater percentage of time in the hyperglycemic state for the daytime interval 
and a lower percentage of time in the hyperglycemic state for the early morning interval. 
The opposite pattern was found for subjects younger than 65. That is subjects younger than 
65 spent a greater percentage of time in hyperglycemia during the early morning interval 
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and a lower percentage of time in hyperglycemia during the daytime interval. The 
difference between the age groups for the percent time hyperglycemic during the day was 
significant, p = 0.02 while a borderline difference was evident during the early morning, p = 
0.06. These effects are displayed in Figure 1 and Table 3. In addition, Figure 2 displays the 
percentage of time in the hyperglycemic state as a function of age for the early morning 
period (A) and for the daytime (B). The distinctive positive and negative effects of increasing 
age has a beneficial effect (lower percentage time in hyperglycemia) during early morning 
and a detrimental effect (higher percentage time in hyperglycemia) during the day. 
Although these effects were not significant, the results are of interest due to the fact that 
clinical evidence of hyperglycemic patterns can help physicians better control glycemic 
excursions. The reasoning behind this finding remains unexplained. 
 
 
Fig. 1. Percent Time Hyperglycemic based on Age and Type of Medication (Oral, Insulin) 
 
 % Time Hyperglycemic from 
 12 am to 6 am 
% Time Hyperglycemic from 
 6 am to 6 pm 
Predictors Beta R2 Beta R2 
BMI 0.68 0.01 -  0.09 0.01 
Systolic Blood 
Pressure 
-0.15 0.02 0.05 0.00 
Hemoglobin A1c 0.31 0.09* - 0.16 0.03 
Age Group 0.24 0.04 ‡ - 0.30 0.07** 
Beta = Standardized Beta  
*p<.05; **p< .01; ‡p < 0.06 
Table 3. Multiple Linear Regressions – Relationship between Age Group and % Time 
Hyperglycemic 
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Fig. 2. Percentage of time spent in hyperglycemia as a function of age during the time 
interval from 12 am to 6 am (A) and from 6 am to 6 pm (B) 
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Multiple linear regressions (Table 4) examine the effects of diabetes treatment type on the 
percentage of time that subjects were in the hyperglycemic state. The groups were analyzed 
based on treatment modality (oral, insulin, or both). To further clarify the analyses only 
those receiving either insulin or oral medication were examined. The results indicated that 
during the early morning period, those taking oral medication exclusively exhibited a lower 
percentage of time in the hyperglycemic state (p = < 0.06). These effects are displayed in 
Figure 3. Similar findings were not found in the other two time periods. 
 
 
% Time Hyperglycemic from 
12 am to 6 am
% Time Hyperglycemic from 6 
am to 6 pm 
Predictors Beta R2 Beta R2 
BMI -0.02 0.00 - 0.11 0.01 
Systolic Blood 
Pressure 
-0.24 0.06* 0.24 0.06* 
Hemoglobin A1c 0.28 0.07* - 0.12 0.01 
Type of Medication 0.22 0.05‡ -0.13 0.02 
Beta = Standardized Beta; Medication Type: Oral= 1, Insulin = 2 
* p< .05; **p< .01; ‡p < 0.06 
Table 4. Multiple Linear Regressions – Relationship between Medication Type (Oral, 
Insulin) and % Time Hyperglycemic 
 
 
Fig. 3. Percent of time spent in hyperglycemia from 12 am to 6 am as a function of age and 
type of medication. 
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Finally to test the hypothesis that age and type of treatment may have interacting effects 
with respect to percentage time in the hyperglycemic state a third multiple regression was 
constructed (Table 5). The Interaction was not significant for either the early morning 
interval or for the daytime interval. Apparently, age and type of treatment have relatively 
independent influences on the percentage of time in the hyperglycemic state. 
 
 % Time Hyperglycemic from 
 12 am to 6 am 
% Time Hyperglycemic from 
 6 am to 6 pm 
Predictors Beta R2 Beta R2 
Hemoglobin A1c 0.31 0.09* - 0.14 0.02 
Age Group 
Medication Type 
Age Group X Type 
0.23 
0.24 
-0.50 
0.04 
0.06* 
0.01 
-0.19 
-0.14 
- 0.47 
0.03 
0.02 
0.01 
Beta = Standardized Beta; Medication Type:  Oral =1, Insulin =2 
*p< .05; **p<.01 
Table 5. Multiple Linear Regressions – Relationship Between the Interaction of Age X 
Medication Type (Oral, Insulin) and % Time Hyperglycemic 
4. Conclusion   
Results from this study demonstrate that both increasing age and the exclusive use of oral 
anti-hyperglycemic medications are associated with a lower percent of time spent in 
hyperglycemia during the early morning. On the other hand, as age increases, the opposite 
effect is exhibited during the daytime interval, namely a higher percent of time in the 
hyperglycemic state. In search for an explanation for these findings there is evidence from 
the animal literature that in older rats, glucose utilization by the brain, using 
autoradiography, tended to increase more slowly in the morning and decrease faster in the 
afternoon and evening (Wise et al., 1988). That is, glucose utilization is overall less effective 
during the day for older rats leading to elevated levels of blood glucose and possibly 
hyperglycemia during the day. Thus, glucose levels in older human subjects (≥65 years) 
compared to younger subjects (<65 years) appear to display a similar pattern as those found 
in the older rats. If the interspecies mechanism is similar, this would give some explanation 
to the pattern of increased percentage of diurnal hyperglycemia found in the older subjects 
with diabetes. 
There was no interaction between age of patient and type of medication administered. 
Therefore, our findings showing that older people and people taking only oral medication 
exhibit less time spent in hyperglycemia during the early morning are two completely 
independent predictors of hyperglycemic episodes and do not influence each other.  
Secondly, elevated HbA1c levels correlated with the percent time spent in a hyperglycemic 
state primarily during the early morning time interval. A study of Type II diabetics revealed 
that non-euglycemic states in the morning (pre-breakfast) and at night (bedtime) correlated 
with increased HbA1c levels. Therefore, patients whose glucose levels were not regulated 
well in the morning or late night tended to have poorer overall glycemic control as 
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measured by HbA1c. Perhaps the reason why the strongest association with HbA1c was 
“exerted” during the night (between the bedtime and pre-breakfast measurements) was due 
to the inability to effectively respond to extreme glucose values while asleep. Thus in the 
absence of an insulin injection (or comparable treatment) to correct for the elevated blood 
glucose levels, these patients may have an overall higher HbA1c. This indicates the 
importance of normalizing glucose levels overnight so as to avoid hyper and hypoglycemic 
states.  
Future studies are needed to help account for the mechanisms behind both the age and 
percent time spent in hyperglycemia as well as the use of oral medication and percent time 
spent in hyperglycemia. Cortisol, for example, has been shown to promote the release of 
large amounts of glucose into the bloodstream as well as to block the absorption of insulin 
and it was shown that cortisol increases with age (Larsson et al., 2009).  Therefore it would 
be beneficial to look further into this relationship as a means of explaining some of our 
results. It was also shown that the amount of REM sleep is reduced by about half in late life. 
This loss of REM sleep has been correlated with elevated cortisol levels throughout the day 
(Van Cauter et al., 2000). Increased cortisol elevates insulin resistance thereby promoting 
hyperglycemic episodes that may be reflected in older subjects with presumptive sleep 
difficulties. 
Among the limitations of the present study is the absence of female subjects.  Also many of 
the Type II diabetics recruited for this study were found to be taking insulin with or without 
oral medication. This led to treatment overlap between the diabetic types making it difficult 
to justify analysis based on type of diabetes, so instead the treatment modality was 
compared. This analytic strategy resulted in the elimination of 15 patients due to their 
treatment plan using both insulin and oral medications.  
In summary, this continuous glucose monitoring study presents some novel observations 
into the relationship between hyperglycemia, advancing age and treatment type.  While 
hypoglycemic episodes may also cause life-threatening situations, prolonged 
hyperglycemic episodes throughout the night, while asleep, will promote life-threatening 
sequellae and reduced quality of life.  Although the complications of hyperglycemia may 
not be as instantaneously debilitating or as acute as hypoglycemia, more research is 
needed to prevent these episodes (Greene et al., 1992; Morello, 2007; Resnikoff et al., 2004). 
By understanding the pathophysiology behind circadian fluctuations of hyperglycemic 
episodes, physicians may be better able to help patients reduce the frequency and 
duration of these occurrences and thus reduce the complications that are associated with 
them. 
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